G2C::Genetics

CYFIP1 knock-out mouse

S.G.N. Grant and the G2C Consortium

Corresponding email: Seth.Grant@ed.ac.uk  

 

G2CMine Data Warehouse

Cyfip1 @ G2CMine

Genetic and Genomic Information

Gene symbol Cyfip1
MGI ID MGI:1338801
G2Cdb mouse G00000324
Ensembl mouse ENSMUSG00000030447
G2Cdb human G00001573
Ensembl human ENSG00000068793

G2CMine Data Warehouse

G2CMine integrates the scientific findings of the Genes to Cognition Programme that utilised neuroproteomics, psychiatric genetics, high-throughput mouse gene targeting combined with behavioural and electrophysiological phenotyping and informatics in order to develop a general strategy for understanding cognition at the molecular, cellular and systems neuroscience levels.

G2CMine provides comprehensive Gene Ontology, Mammalian Phenotype Ontology, Human Phenotype Ontology, UniProt, genetic and protein interactions, and regional mouse brain expression results, together with the phenotyping results of the G2C Programme.

Mutation

Enlarge this image (940 x 780)

CYFIP1 mice were supplied by the Mouse Genome Project (Sanger Institute).

Generation of Cyfip1 targeted mice A. Cyfip1 is a 31 exon gene which encodes a Cytoplasmic FMR1-interacting domain (top). A selection cassette was inserted into intron 3-4 whilst exons 4-6 were floxed creating a frame shift between exons 3 and 7. Primers used for genotyping PCR (A,B & C) and RT-PCR (Y and Z) are shown.

Genotyping

Enlarge this image (1384 x 448)

Genomic DNA was isolated from ES cells by Wizard SV 96 Genomic DNA purification system (Promega Cat A2371). Genotyping PCR consisted of a 211bp product amplified from the wild-type (wt) allele using a forward primer A (GTGCTGTAAGAAGCAGGCTG) and reverse primer B (CTGCCACAGAGATACATCTTG). A 466bp product was amplified from the targeted allele using forward primer C (CCTCCCCCTGAACCTGAAAC) with reverse primer B. After enzymatic amplification for 35 cycles (45 seconds at 94 °C, 45 seconds at 55 °C, and 1 minute at 72 °C), the PCR products were size-fractionated on a 2% agarose gel in 1x Tris borate-EDTA buffer.

Primers used for genotyping (A,B & C). PCR genotyping of targeted CYFIP1 mice using a common reverse primer, B, and forward primers A and C to amplify the wt and mutant alleles respectively.

Expression

Enlarge this image (1278 x 423)

Total RNA was extracted from whole mouse brain using RNeasy Midi kit (Qiagen, Cat 75144). RT-PCR was performed by generating first strand cDNA and using forward primer, Y (CATGTTTGCTGTGTTGGATG), which anneals to exon 6 and reverse primer, Z (GTCAAGTACATCCTGTTCTC), which anneals to exon 8. A product of 270bp was generated from WT cDNA and a weaker product was detected from heterozygote cDNA where the exons have been replaced by the cassette.

Primers used for RT-PCR (Y & Z) RT-PCR genotyping using forward primer Y, in exon 6, and reverse primer Z, in exon 8. A product of 270bp was generated from WT cDNA and weaker product was detected from heterozygote cDNA where the exons have been replaced by the cassette.

Breeding

CYFIP1-/- mice were known to be lethal so CYFIP1+/- mice were produced for phenotypic analysis. Male and female CYFIP1+/- developed normally to adulthood, were fertile, exhibited normal body size and no gross abnormalities. Genotypes of 3-week-old pups from CYFIP1+/- back-crosses identified 38 wildtype and 23 CYFIP1+/- progeny. Backcrosses onto the C57BL/6J background were used to maintain the colony.

Overview

Mutant slices showed little overall electrophysiological difference from wildtype slices, with two of nine variables significantly impacted by this mutation. In the theta burst stimulation experiment, two electrophysiological variables of five were significantly impacted in mutants. Basal synaptic transmission, paired pulse facilitation and long term potentiation experiments were unaffected. Note that in the theta burst analysis, the tenth burst is analysed as representative of individual burst amplitude. Definitions of variables may be found below.

Enlarge this image (600 x 700)

The G2CMine data warehouse provides slice group summaries and individual mouse observations from the CYFIP1 knock-out line phenotyping.

 

Variables shown are: Max fEPSP amplitude, Maximum field excitatory postsynaptic potential (fEPSP) amplitude. PPF at 50ms, ampl ratio, Paired pulse facilitation (PPF), pulses separated by 50ms, amplitude ratio. Burst 1, PPF at 10ms, ampl ratio, Paired pulse facilitation (PPF), pulses separated by 10ms, amplitude ratio, observed during first two pulses of the first 100Hz burst during theta-burst stimulation. Burst 1, EPSP3 depr, ampl ratio, Depression observed in third fEPSP relative to the second fEPSP of the first 100Hz burst, amplitude ratio. Burst 1, ave amplitude, Average amplitude of four fEPSPs in first burst. Burst 2, ave amplitude, Average amplitude of four fEPSPs in second burst. Burst 3, ave amplitude, Average amplitude of four fEPSPs in third burst. Burst 4, ave amplitude, Average amplitude of four fEPSPs in fourth burst. Burst 5, ave amplitude, Average amplitude of four fEPSPs in fifth burst. Burst 6, ave amplitude, Average amplitude of four fEPSPs in sixth burst. Burst 7, ave amplitude, Average amplitude of four fEPSPs in seventh burst. Burst 8, ave amplitude, Average amplitude of four fEPSPs in eighth burst. Burst 9, ave amplitude, Average amplitude of four fEPSPs in ninth burst. Burst 10, ave amplitude, Average amplitude of four fEPSPs in tenth burst. Burst 2-4 ave amplitude vs Burst 1, Facilitation observed in average amplitude of bursts 2-4, relative to average amplitude of burst 1. Burst 8-10 ave amplitude vs Burst 2-4, Depression observed in average amplitude of bursts 8-10, relative to average amplitude of bursts 2-4. LTP vs PTP, amplitude ratio, Reduction in potentiation from immediately after theta-burst stimulation to one hour later, fEPSP amplitude ratio. LTP based on amplitude, Long term potentiation, ratio of amplitudes of fEPSPs in test pathway and control pathway.

 

Variable Units Wildtype slices (animals) Wildtype mean (SEM) Mutant slices (animals) Mutant mean (SEM) P(animals) P(mutation)
Max fEPSP amplitude µV 36 (12) 3290 (110) 23 (8) 3260 (180) 0.048 * 0.91
PPF at 50ms, ampl ratio % 36 (12) 172.4 (2.3) 23 (8) 182.2 (3.5) 0.072 0.064
Burst 1, PPF at 10ms, ampl ratio % 36 (12) 183.2 (3.6) 23 (8) 204.7 (5.5) 0.2 0.0084 **
Burst 1, EPSP3 depr, ampl ratio % 36 (12) 65.3 (1.5) 23 (8) 57.5 (2.4) 0.1 0.024 *
Burst 1, ave amplitude µV 36 (12) 1347 (39) 23 (8) 1345 (72) 0.18 0.98
Burst 2, ave amplitude µV 36 (12) 2132 (73) 23 (8) 2118 (109) 0.1 0.93
Burst 3, ave amplitude µV 36 (12) 2396 (77) 23 (8) 2397 (120) 0.083 1
Burst 4, ave amplitude µV 36 (12) 2453 (75) 23 (8) 2455 (117) 0.076 0.99
Burst 5, ave amplitude µV 36 (12) 2409 (70) 23 (8) 2411 (108) 0.098 0.99
Burst 6, ave amplitude µV 36 (12) 2340 (67) 23 (8) 2342 (102) 0.099 0.99
Burst 7, ave amplitude µV 36 (12) 2250 (62) 23 (8) 2268 (96) 0.11 0.89
Burst 8, ave amplitude µV 36 (12) 2173 (59) 23 (8) 2188 (92) 0.082 0.9
Burst 9, ave amplitude µV 36 (12) 2104 (57) 23 (8) 2127 (89) 0.06 0.86
Burst 10, ave amplitude µV 36 (12) 2050 (58) 23 (8) 2076 (88) 0.079 0.83
Burst 2-4 ave amplitude vs Burst 1 % 36 (12) 173.6 (2.5) 23 (8) 174.6 (3.5) 0.012 * 0.86
Burst 8-10 ave amplitude vs Burst 2-4 % 36 (12) 91.2 (1.1) 23 (8) 92.2 (1.1) 0.044 * 0.64
LTP vs PTP, amplitude ratio % 36 (12) 80.5 (0.6) 23 (8) 80.5 (0.9) 0.33 0.97
LTP based on amplitude % 36 (12) 176 (2.1) 23 (8) 175.7 (2.7) 0.6 0.93

Basal Synaptic Transmission

Enlarge this image (800 x 600)

Enlarge this image (640 x 480)

 

Variables shown are: Max fEPSP amplitude, Maximum field excitatory postsynaptic potential (fEPSP) amplitude.

 

Variable Units Wildtype slices (animals) Wildtype mean (SEM) Mutant slices (animals) Mutant mean (SEM) P(animals) P(mutation)
Max fEPSP amplitude µV 36 (12) 3290 (110) 23 (8) 3260 (180) 0.048 * 0.91

Paired Pulse Facilitation

Enlarge this image (800 x 600)

Enlarge this image (640 x 480)

 

Variables shown are: PPF at 50ms, ampl ratio, Paired pulse facilitation (PPF), pulses separated by 50ms, amplitude ratio.

 

Variable Units Wildtype slices (animals) Wildtype mean (SEM) Mutant slices (animals) Mutant mean (SEM) P(animals) P(mutation)
PPF at 50ms, ampl ratio % 36 (12) 172.4 (2.3) 23 (8) 182.2 (3.5) 0.072 0.064

Theta Burst Stimulation

Enlarge this image (640 x 480)

Enlarge this image (640 x 480)

Enlarge this image (640 x 480)

Enlarge this image (640 x 480)

Enlarge this image (640 x 480)

Enlarge this image (640 x 480)

Enlarge this image (640 x 480)

Enlarge this image (640 x 480)

Enlarge this image (640 x 480)

Enlarge this image (640 x 480)

Enlarge this image (640 x 480)

Enlarge this image (640 x 480)

Enlarge this image (800 x 600)

Enlarge this image (640 x 480)

Enlarge this image (640 x 480)

 

Variables shown are: Burst 1, PPF at 10ms, ampl ratio, Paired pulse facilitation (PPF), pulses separated by 10ms, amplitude ratio, observed during first two pulses of the first 100Hz burst during theta-burst stimulation. Burst 1, EPSP3 depr, ampl ratio, Depression observed in third fEPSP relative to the second fEPSP of the first 100Hz burst, amplitude ratio. Burst 1, ave amplitude, Average amplitude of four fEPSPs in first burst. Burst 2, ave amplitude, Average amplitude of four fEPSPs in second burst. Burst 3, ave amplitude, Average amplitude of four fEPSPs in third burst. Burst 4, ave amplitude, Average amplitude of four fEPSPs in fourth burst. Burst 5, ave amplitude, Average amplitude of four fEPSPs in fifth burst. Burst 6, ave amplitude, Average amplitude of four fEPSPs in sixth burst. Burst 7, ave amplitude, Average amplitude of four fEPSPs in seventh burst. Burst 8, ave amplitude, Average amplitude of four fEPSPs in eighth burst. Burst 9, ave amplitude, Average amplitude of four fEPSPs in ninth burst. Burst 10, ave amplitude, Average amplitude of four fEPSPs in tenth burst. Burst 2-4 ave amplitude vs Burst 1, Facilitation observed in average amplitude of bursts 2-4, relative to average amplitude of burst 1. Burst 8-10 ave amplitude vs Burst 2-4, Depression observed in average amplitude of bursts 8-10, relative to average amplitude of bursts 2-4.

 

Variable Units Wildtype slices (animals) Wildtype mean (SEM) Mutant slices (animals) Mutant mean (SEM) P(animals) P(mutation)
Burst 1, PPF at 10ms, ampl ratio % 36 (12) 183.2 (3.6) 23 (8) 204.7 (5.5) 0.2 0.0084 **
Burst 1, EPSP3 depr, ampl ratio % 36 (12) 65.3 (1.5) 23 (8) 57.5 (2.4) 0.1 0.024 *
Burst 1, ave amplitude µV 36 (12) 1347 (39) 23 (8) 1345 (72) 0.18 0.98
Burst 2, ave amplitude µV 36 (12) 2132 (73) 23 (8) 2118 (109) 0.1 0.93
Burst 3, ave amplitude µV 36 (12) 2396 (77) 23 (8) 2397 (120) 0.083 1
Burst 4, ave amplitude µV 36 (12) 2453 (75) 23 (8) 2455 (117) 0.076 0.99
Burst 5, ave amplitude µV 36 (12) 2409 (70) 23 (8) 2411 (108) 0.098 0.99
Burst 6, ave amplitude µV 36 (12) 2340 (67) 23 (8) 2342 (102) 0.099 0.99
Burst 7, ave amplitude µV 36 (12) 2250 (62) 23 (8) 2268 (96) 0.11 0.89
Burst 8, ave amplitude µV 36 (12) 2173 (59) 23 (8) 2188 (92) 0.082 0.9
Burst 9, ave amplitude µV 36 (12) 2104 (57) 23 (8) 2127 (89) 0.06 0.86
Burst 10, ave amplitude µV 36 (12) 2050 (58) 23 (8) 2076 (88) 0.079 0.83
Burst 2-4 ave amplitude vs Burst 1 % 36 (12) 173.6 (2.5) 23 (8) 174.6 (3.5) 0.012 * 0.86
Burst 8-10 ave amplitude vs Burst 2-4 % 36 (12) 91.2 (1.1) 23 (8) 92.2 (1.1) 0.044 * 0.64

Long Term Potentiation

Enlarge this image (800 x 600)

Enlarge this image (640 x 480)

Enlarge this image (640 x 480)

 

Variables shown are: LTP vs PTP, amplitude ratio, Reduction in potentiation from immediately after theta-burst stimulation to one hour later, fEPSP amplitude ratio. LTP based on amplitude, Long term potentiation, ratio of amplitudes of fEPSPs in test pathway and control pathway.

 

Variable Units Wildtype slices (animals) Wildtype mean (SEM) Mutant slices (animals) Mutant mean (SEM) P(animals) P(mutation)
LTP vs PTP, amplitude ratio % 36 (12) 80.5 (0.6) 23 (8) 80.5 (0.9) 0.33 0.97
LTP based on amplitude % 36 (12) 176 (2.1) 23 (8) 175.7 (2.7) 0.6 0.93
© G2C 2014. The Genes to Cognition Programme received funding from The Wellcome Trust and the EU FP7 Framework Programmes:
EUROSPIN (FP7-HEALTH-241498), SynSys (FP7-HEALTH-242167) and GENCODYS (FP7-HEALTH-241995).

Cookies Policy | Terms and Conditions. This site is hosted by Edinburgh University and the Genes to Cognition Programme.